OGN
Organon & Co.
NYSE · USHealthcareDrug Manufacturers - General
$13.49-0.22%
Price as of Jul 20, 2026
OGN capital
Organon & Co. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 9.49x
- Net debt / equity
- 8.25x
- Debt / assets
- 0.66x
- Debt / EBITDA
- 6.20x
- Net debt / EBITDA
- 5.39x
Liquidity & coverage
- Current ratio
- 1.97x
- Quick ratio
- 1.42x
- Cash ratio
- 0.45x
- Interest coverage
- 2.41x
- EBITDA / interest
- 2.81x
- Working capital
- $2.4B
Cash & dividend
- FCF / debt
- 0.07x
- Cash flow / debt
- 0.10x
- Dividend per share
- $0.08
- Dividend yield
- 0.6%
- Dividend growth 1y
- -69.6%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.